Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1805 1
1970 1
1973 1
1974 1
1975 1
1977 2
1980 2
1981 2
1982 2
1983 2
1984 2
1985 3
1986 2
1987 5
1988 2
1989 2
1990 1
1992 1
1993 3
1994 4
1995 1
1997 7
1998 3
1999 7
2000 8
2001 18
2002 7
2003 14
2004 15
2005 14
2006 11
2007 23
2008 27
2009 32
2010 34
2011 29
2012 35
2013 27
2014 21
2015 33
2016 38
2017 36
2018 37
2019 46
2020 48
2021 29
2022 49
2023 31
2024 24
2025 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

667 results

Results by year

Filters applied: . Clear all
Page 1
Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma.
Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Le Cesne A, Balleyguier C, Archambaud B, Duffaud F; French Sarcoma Group. Pautier P, et al. N Engl J Med. 2024 Sep 5;391(9):789-799. doi: 10.1056/NEJMoa2403394. N Engl J Med. 2024. PMID: 39231341 Free article. Clinical Trial.
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.
Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Balleyguier C, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bardet A, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Archambaud B, Duffaud F; French Sarcoma Group. Pautier P, et al. Lancet Oncol. 2022 Aug;23(8):1044-1054. doi: 10.1016/S1470-2045(22)00380-1. Epub 2022 Jul 11. Lancet Oncol. 2022. PMID: 35835135 Free article. Clinical Trial.
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.
Belmontes B, Slemmons KK, Su C, Liu S, Policheni AN, Moriguchi J, Tan H, Xie F, Aiello DA, Yang Y, Lazaro R, Aeffner F, Rees MG, Ronan MM, Roth JA, Vestergaard M, Cowland S, Andersson J, Sarvary I, Chen Q, Sharma P, Lopez P, Tamayo N, Pettus LH, Ghimire-Rijal S, Mukund S, Allen JR, DeVoss J, Coxon A, Rodon J, Ghiringhelli F, Penel N, Prenen H, Glad S, Chuang CH, Keyvanjah K, Townsley DM, Butler JR, Bourbeau MP, Caenepeel S, Hughes PE. Belmontes B, et al. Cancer Discov. 2025 Jan 13;15(1):139-161. doi: 10.1158/2159-8290.CD-24-0887. Cancer Discov. 2025. PMID: 39282709 Free PMC article.
[Epithelioid hemangioendothelioma].
Cousin S, Le Loarer F, Crombé A, Karanian M, Minard-Colin V, Penel N. Cousin S, et al. Bull Cancer. 2019 Jan;106(1):73-83. doi: 10.1016/j.bulcan.2018.11.004. Epub 2018 Dec 4. Bull Cancer. 2019. PMID: 30527817 Review. French.
[Dermatofibrosarcoma: Management].
Penel N, El Bedoui S, Robin YM, Decanter G. Penel N, et al. Bull Cancer. 2018 Nov;105(11):1094-1101. doi: 10.1016/j.bulcan.2018.08.008. Epub 2018 Oct 5. Bull Cancer. 2018. PMID: 30297237 Review. French.
An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).
Kasper B, Baumgarten C, Garcia J, Bonvalot S, Haas R, Haller F, Hohenberger P, Penel N, Messiou C, van der Graaf WT, Gronchi A; Desmoid Working Group. Kasper B, et al. Ann Oncol. 2017 Oct 1;28(10):2399-2408. doi: 10.1093/annonc/mdx323. Ann Oncol. 2017. PMID: 28961825 Free PMC article. Review.
Are the Pieces Starting to Come Together for Management of Desmoid Tumors?
Greene AC, Van Tine BA. Greene AC, et al. Clin Cancer Res. 2022 Sep 15;28(18):3911-3913. doi: 10.1158/1078-0432.CCR-22-0620. Clin Cancer Res. 2022. PMID: 35819317
See related articles by Colombo et al., p. 4027, Nathenson et al., p. 4092, and Penel et al., p. 4105....
See related articles by Colombo et al., p. 4027, Nathenson et al., p. 4092, and Penel et al., p. 4105....
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY. Penel N, et al. J Clin Oncol. 2008 Nov 10;26(32):5269-74. doi: 10.1200/JCO.2008.17.3146. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809609 Clinical Trial.
[Cancer screening words].
Mathoulin-Pélissier S, Penel N. Mathoulin-Pélissier S, et al. Bull Cancer. 2019 Jul-Aug;106(7-8):608-614. doi: 10.1016/j.bulcan.2019.03.004. Epub 2019 Apr 16. Bull Cancer. 2019. PMID: 31003632 French. No abstract available.
Regorafenib for the Treatment of Sarcoma.
Blay JY, Duffaud F, George S, Maki RG, Penel N. Blay JY, et al. Curr Treat Options Oncol. 2022 Nov;23(11):1477-1502. doi: 10.1007/s11864-022-00990-0. Epub 2022 Sep 30. Curr Treat Options Oncol. 2022. PMID: 36178573 Review.
667 results